Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Identification of Fatty Acids in Bacillus cereus08:41

Identification of Fatty Acids in Bacillus cereus

10.1K
We propose a protocol to identify fatty acids without the need to purify them. It combines information on the retention times with the mass spectra of three types of fatty acid derivatives: fatty acid methyl esters (FAMEs), 4,4-dimethyl oxazoline derivatives (DMOX), and 3-pyridylcarbinyl esters (picolinyl).
10.1K
Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

28.6K
This protocol describes the porcine myocardial infarction (MI) model using a 90 min closed-chest coronary balloon occlusion of the left anterior descending artery (LAD), followed by reperfusion. Furthermore, the protocol for several outcome parameters, such as cardiac function, hemodynamics, microvascular resistance, and infarct size, are also...
28.6K
Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography05:03

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography

1.6K
Here, a normal-phase, high-performance liquid chromatography method is described to detect and quantify critical retinoids involved in the facilitation of visual function in both ocular and systemic tissue, in the context of the systemic vitamin A supply to generate the essential photosensitive rhodopsin chromophore...
1.6K
A Two-Step Protocol for Umpolung Functionalization of Ketones Via Enolonium Species08:12

A Two-Step Protocol for Umpolung Functionalization of Ketones Via Enolonium Species

10.5K
A two step one-pot protocol for the umpolung of ketone enolates to enolonium species and addition of a nucleophile to the α-position is described. Nucleophiles include chloride, azide, azoles, allyl-silanes, and aromatic...
10.5K
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments10:59

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments

1.7K
This protocol details the glycomics-guided glycoproteomics method, an integrated omics technology that offers comprehensive insights into the heterogeneous glycoproteome in complex tumor microenvironments required to better understand the glycobiology of...
1.7K
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

20.4K
Here we describe a protocol for multiplex fluorescent immunohistochemical staining and imaging for the simultaneous localization of multiple cancer-associated antigens in lymphoma. This protocol can be extended to the colocalization analysis of biomarkers within all tissue...
20.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Recommendations for Augmentation Agents in Obsessive-Compulsive Disorder Partially Responsive to Serotonin Reuptake Inhibitors.

Journal of clinical psychopharmacology·2023
Same author

Letter to the Editor: Protracted Neutropenia After Treatment With Non-Clozapine Antipsychotic Medications.

Journal of clinical psychopharmacology·2022
Same author

Catatonia and Schizophrenia in a Young Man with Autism Spectrum Disorder and Clozapine-Induced Myocarditis.

Harvard review of psychiatry·2022
Same author

Kratom & Stimulant Co-Addiction: A Case Series and Brief Review.

Journal of addictive diseases·2022
Same author

Practice patterns of bupropion co-prescription with antipsychotic medications.

Journal of addictive diseases·2022
Same author

The Danger of Face Masks on an Inpatient Psychiatric Unit: New Protocol to Prevent Self-harm.

The primary care companion for CNS disorders·2021
Same journal

Communicating With Intubated Patients: Challenges Faced by Health Care Providers, Patients, and Family Members.

The primary care companion for CNS disorders·2026
Same journal

Fluoxetine-Induced Liver Injury in a Patient With Post-Schizophrenic Depression.

The primary care companion for CNS disorders·2026
Same journal

Beyond Pharmacology: Do Tablet Shape, Size, and Color Influence Medication Adherence in Psychiatric Outpatients?

The primary care companion for CNS disorders·2026
Same journal

Daily Fantasy Sports as an Emerging Public Health Concern: A Comparative Public Health Perspective of Digital Wagering and Youth Vulnerability.

The primary care companion for CNS disorders·2026
Same journal

Psychological Adverse Effects of Psychedelic Use.

The primary care companion for CNS disorders·2026
Same journal

Medical Complications of Psychedelics.

The primary care companion for CNS disorders·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Identification of Fatty Acids in Bacillus cereus
08:41

Identification of Fatty Acids in Bacillus cereus

Published on: December 5, 2016

10.1K

Levomilnacipran: More of the Same?

Mohan Gautam1,2, Madhupreet Kaur3, Pranav Jagtap2

  • 1Department of Psychiatry, Henry Ford System/Wayne State University, 2799 West Grand Blvd, Detroit, MI 48202. mgautam1@hfhs.org.

The Primary Care Companion for CNS Disorders
|September 12, 2019
PubMed
Summary
This summary is machine-generated.

Levomilnacipran shows promise in treating major depressive disorder (MDD), particularly its fatigue symptoms. Further research is needed to confirm its unique benefits over other antidepressants.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.6K
Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
05:03

Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling

Published on: December 27, 2024

1.6K

Related Experiment Videos

Last Updated: Jan 19, 2026

Identification of Fatty Acids in Bacillus cereus
08:41

Identification of Fatty Acids in Bacillus cereus

Published on: December 5, 2016

10.1K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.6K
Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
05:03

Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling

Published on: December 27, 2024

1.6K

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Medicine

Background:

  • Major Depressive Disorder (MDD) is a prevalent mental health condition.
  • Fatigue is a common and debilitating symptom cluster in MDD.
  • Existing antidepressants like SSRIs and SNRIs have varying efficacy in managing MDD symptoms.

Purpose of the Study:

  • To analyze the mechanism of action, pharmacokinetics, toxicology, and efficacy of levomilnacipran.
  • To investigate levomilnacipran's potential unique role in alleviating fatigue in MDD.
  • To provide clinicians with an in-depth understanding of levomilnacipran.

Main Methods:

  • A comprehensive literature review was conducted using PubMed with the MeSH term 'levomilnacipran'.
  • Inclusion criteria focused on English-language randomized controlled trials and systematic reviews published up to March 2019.
  • Data from 31 selected articles were analyzed, excluding anecdotal reports and product labels.

Main Results:

  • Evidence suggests levomilnacipran is effective in the treatment of MDD.
  • Data indicate levomilnacipran may uniquely improve the fatigue symptom cluster in MDD compared to SSRIs and SNRIs.
  • Levomilnacipran's efficacy in treating MDD, especially fatigue, is supported by analyzed trial data.

Conclusions:

  • Levomilnacipran demonstrates potential as a unique treatment for the fatigue associated with MDD.
  • Further investigation is warranted to confirm levomilnacipran's specific benefits for MDD-related fatigue.
  • Future research should include head-to-head studies and assessments of clinically relevant fatigue improvements.